Melbourne, Feb 9, 2009 (ABN Newswire) - Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that there had been unprecedented interest in the update on the City of Hope HIV trial recently presented in the USA.
